EUVIMED · CrossrefZeitschrift
Nature Cancer
ISSN 2662-1347 · Springer Science and Business Media LLC
Neueste Artikel
A single-cell lung cancer atlas reveals cellular and molecular drivers of metastasis and clinical outcome
Natural killer cell inflammatory circuits in antitumor immunity
Spatiotemporal control of CAR-T cell TNF release via tumor-targeted irradiation
Basophils boost early antitumor immunity by restraining Treg cells
Basophils inhibit early lung metastasis by suppressing regulatory T cells
Myeloid-derived TGFβ1 and oncostatin M establish two distinct stromal niches controlling late and hybrid EMT states
Oncostatin M and TGFβ1 divide the epithelial–mesenchymal landscape
Targeting GALE harnesses γδ T cells for cancer immunotherapy
GALE is a tumor-intrinsic checkpoint of Vγ9Vδ2 T cell-mediated killing
ANO6-mediated trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer cell growth and immune suppression
BAZ2A-induced epigenetic states in cancer cells fuel palmitate accumulation in the tumor microenvironment driving CAR-T cell exhaustion
AI for detection of adverse events in the real world
A genome‑wide screen in E. coli reveals metabolic adaptations that enhance intratumoral fitness and bacterial cancer therapy efficacy
An agentic AI system enhances clinical detection of immune-related adverse events in a multi-phase validation study
Stroke drives glioma progression through the emergence of tumor-associated astrocytes with reduced Ca2+ activity
An iron-regulated methionine redox axis governs adipose browning and cancer cachexia
MMSDH facilitates ACSL4 propionylation to counteract ferroptosis upon hypoxia and impairs PDAC chemotherapy efficacy
Commensal Nakaseomyces glabratus migrates into prostate tumors to accelerate cancer progression
l-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial
Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose
Charting intratumor heterogeneity from bench to bedside
Immune implications and therapeutic opportunities of tumor glycosylation
A micropeptide encoded by the lncRNA USP30-AS1 promotes tumor growth by attenuating cGAS–STING–type I IFN signaling in macrophages
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets
Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial
Bacterial engineering for cancer therapy
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial
Copper depletion boosts CNS leukemia therapy by inhibiting nucleotide synthesis through impairment of mitochondrial complex IV activity
EUVIMED